Refine
Has Fulltext
- yes (46)
Is part of the Bibliography
- yes (46)
Year of publication
Document Type
- Doctoral Thesis (46) (remove)
Language
- English (46) (remove)
Keywords
- Escherichia coli (8)
- Candida albicans (5)
- Dendritische Zelle (4)
- Genexpression (4)
- Malaria (4)
- Genregulation (3)
- Leishmania major (3)
- Pathogenität (3)
- Small RNA (3)
- Bacteria (2)
Institute
- Institut für Molekulare Infektionsbiologie (46) (remove)
Sonstige beteiligte Institutionen
The prevention of restenosis after percutaneous coronary intervention is a major task for researchers and clinicians in cardiovascular pharmacology. Nearly 1.5 million PTCA are performed every year worldwide and, due to the implantation of stents, most of the cases can be treated successfully. 60% of those patients develop restenosis within 6 months. SMC migration and ECM deposition are known to be responsible for neointima formation. Among many processes, integrin initiated signalling events play a central role in SMC migration. Many integrins recognize a specific RGD sequence which is present in several ECM proteins and cell surface immunoglobulin super family molecules. Until now, there are various integrin antagonists such as antibodies, cyclic peptides, peptidomimetics, and non-peptides have been shown to interfere with such pathological situations indicating the importance of integrin initiated signalling pathways in SMC migration. Therefore, in this study SMC migration induced by ECM proteins was inhibited either using pharmacological inhibitor or by overexpressing the endogenous inhibitor of FAK by AAV vector system. In the first part of the thesis, the effect of integrin-ligand stimulation on hCASMCs was studied. The tyrosine phosphorylation of many cellular proteins was observed from serum starved hCASMCs replated on VN but not on PL coated plates. The major tyrosine phosphorylated protein was identified as FAK by immunoprecipitation and also phosphorylation was found at Tyr 397, the autophosphorylation site of FAK. Further, VN induced the dose dependent migration of hCASMCs in haptotaxis assay. The integrin v inhibitor was used to block those ECM stimulated integrin signalling pathways and cell migration. It inhibited the ECM stimulated tyrosine phosphorylation in a dose dependent manner. Interestingly, specific potent antagonism of integrin v abrogated both ECM induced haptotaxis and growth factor induced chemotaxis. The inhibition of migration is consistent with the replating assay results that show interference with integrin induced signalling pathways particularly the FAK tyrosine phosphorylation. The integrin v inhibitor also is able to interfere with hCASMC invasion through matrigel by reducing MMP-2 secretion. Importantly, integrin v inhibitor did not induce the apoptosis in hCASMCs. FAK is a key player in many cellular events and its involvement in cell migration was extensively studied in various cell types. The present study explored the function of FAK in hCASMC migration by overexpression of FRNK, the C-terminal domain of FAK. Overexpression of FRNK inhibited the in vitro SMC migration as well as the neointima formation in a porcine restenosis model in vivo. The last part of this thesis focused on the identification of putative binding partners for the N-terminal domain of FAK by bacterial two-hybrid screen. One of the interesting binding partners was a putative protein of 17.9 kDa. Its human homolog is AGS4, which acts as a GTPase activator. The preliminary results revealed that it is able to interact with N-FAK domain and its expression is high in haematopoietic cells. Taken together the above results suggest that integrin v and FAK are promising targets for inhibition of SMC migration. Disruption of FAK-mediated signalling pathways by a pharmacological inhibitor or by overexpression of FRNK, which acts as dominant-negative regulator, resulted in decreased migration of SMCs and thus can lead to reduction of neointima formation.
The establishment of genomic approaches including the sequence determination of complete bacterial genomes started a new era in microbiological research. Since then more than two hundred prokaryotic and eukaryotic genomes have been completely sequenced, and there are additional complete genome projects including different bacterial species and strains in progress (http://www.tigr.org, http://www.sanger.ac.uk). The continously growing amount of bacterial DNA sequence information gives us also the possibility to gain deeper insight into bacterial pathogenesis. With the help of comparative genomics, microbiological research can focus on those DNA sequences that are present in pathogenic bacteria but are absent in non-pathogenic strains. With this knowledge and with the help of molecular biological methods such as PCR,DNA-chip technology, subtractive hybridisation, transcriptomics and proteomics we can analyse in detail what makes a particular bacterial strain pathogenic. This knowledge also gives us the possibility to develop new vaccines, therapeutic approaches or diagnostic tools. The aim of this work was the structural and functional analysis of DNA regions of uropathogenic Escherichia coli strain 536 that belong to the flexible E. coli gene pool. The first part of this thesis focused on the identification and structural characterisation of pathogenicity island V of strain 536 (PAI V536). PAI V536 is integrated at the pheV tRNA gene at 64 minutes of the E. coli K-12 chromosome. In addition to the intact pheV tRNA gene, a truncated copy ('pheV) that represents the last 22 bp of this gene’s 3'-end was identified 49 kb downstream of pheV on PAI V536. The analysis of the DNA sequence flanked by pheV and 'pheV revealed characteristics that are typical of PAIs. This DNA region exhibits homology to IS-elements and prophages and also comprises determinants coding for the Pix fimbriae, a phosphoglycerate transport system, an autotransporter, as well as for hypothetical proteins. Downstream of 'pheV, the K15 capsule determinant (kpsK15) of this strain is located. Structural analysis of the 20-kb kpsK15 locus revealed a so far unknown genetic organisation indicative of recombination events between a group 2 and group 3 capsule gene cluster. Downstream of the capsule determinant, the genes encoding a type II secretion system (general secretion pathway -GSP) are located on PAI V536. The K15 capsule locus was functionally characterized. Specific inactivation of each of the regions 1 to 3 of the kpsK15 gene cluster, and the use of a K15 capsule-specific antiserum demonstrated that this determinant is the functional K15 capsule locus of strain 536. It has been shown in an experimental murine model of ascending urinary tract infection with suckling mice that the K15 capsule contributes to urovirulence. Interestingly, the K15 capsule is not involved in serum resistance of strain 536. Inactivation of the PAI V536-encoded type II secretion system excluded a role of this general secretion pathway for capsule biosynthesis and virulence of strain 536 in the murine ascending urinary tract infection model. In the second part of the thesis, the transferability of PAIs was further investigated. Using PAI II536 as a model, mobilisation of this island from strain 536 into suitable recipient strains was investigated. For this purpose, an antibiotic resistance cassette, the R6K origin of replication as well as plasmid pGP704 carrying the mobilisation region of plasmid RP4 have been inserted into PAI II536. Transformation with the helper plasmid RP4, resulted a derivative of strain 536 that was used as a donor for conjugation experiments, while for recipient the pir + laboratory strain SY327 was used. After deletion the circularised PAI II536 was mobilised with the help of the conjugative helper plasmid (RP4) into the recipient laboratory strain SY327. The frequency of this event was about 10-8. It was also demonstrated that in the transconjugant strains the mobilized PAI II536 could be permanently present as a circular form and also can be integrated into the chromosome at the same chromosomal insertion site (leuX) as in the donor strain 536. Furthermore, after mobilisation and chromosomal integration of PAI II536 it was possible to remobilise this PAI back to a PAI II536-negative derivative of strain 536. The results obtained in this thesis increase our knowledge of the structure and function of a pathogenicity island of uropathogenic E. coli strain 536 and shed some light on the mechanisms contributing to genome plasticity and evolution of pathogenic E. coli variants.
According to the hygiene hypothesis, the exposure to infectious agents in early childhood prevents the development of allergen-specific Th2 immune responses because it establishes Th1-based immunity or alternatively, induces the generation of T regulatory cells. Based on this theory, the present study pretended to identify promising microorganism-derived vaccine candidates against allergic asthma in the murine model. In the first part of this work, the efficacy of four different known Th1-inducing adjuvants, i.e. live BCG, heat-killed BCG, CpG and PPD, as components of vaccines aimed at inhibiting allergic asthma was compared. All the adjuvants were effective in inhibiting the development of allergen-induced airway eosinophilia, mucus production, and with the exception of PPD also airway hyperreactivity (AHR), when they were applied together with OVA/alum. Suppression of airway eosinophilia was not observed in IFN-gamma- or IL-12-deficient mice (hk-BCG, CpG-ODN and PPD). Interestingly, live BCG was still able to suppress allergen-induced Th2 responses in the absence of either IFN-gamma or IL-12. The effect of live BCG was also independent on IL-10-, TLR-2-, TLR-4- or MyD88-mediated signaling. When mice vaccinated with the different adjuvants together with OVA/alum were subjected to a second period of OVA/alum immunization, only live and hk-BCG were able to efficiently suppress the development of airway inflammation. This effect could be adoptively transferred by CD4+ T cells. Taken together our data suggest that live BCG>>hk-BCG>CpG>PPD are effective in suppressing allergen-induced Th2 responses. Secondly, the evaluation of a dendritic cell-based vaccination strategy leading to the induction of allergen-specific Th1 cells to protect against the development of allergen-specific Th2 responses was performed. The application of OVA-pulsed BM-DC maturated with CpG was unable to reduce airway eosinophilia and inflammation in OVA-immunized mice. OVA-specific IgG1 or IgE serum levels were also not reduced. The experiments using LC pulsed with OVA yielded similar results. However, the mice vaccinated with CpG/OVA pulsed BM-DC had greatly enhanced levels of OVA-specific IgG2a in the serum, suggesting the induction of allergen-specific Th1 responses in vivo. Thus, these data suggest that the vaccination of mice with OVA-pulsed BM-DC matured with CpG or OVA-pulsed LC did not result in a reduction of allergen-specific Th2 responses in a murine model of severe atopic asthma. Lastly, NES, an excretory/secretory product derived from the helminth Nippostrongylus brasiliensis was evaluated as a new potential adjuvant to prevent the development of allergic responses. The application of NES together with OVA/alum greatly inhibited the development of airway eosinophilia, airway goblet cell metaplasia and mucus production and the development of airway hyperreactivity after metacholine challenge. Furthermore, OVA-specific IgG1 and IgE levels in the serum were also strongly reduced. NES preparations contained small amounts of endotoxin, which may explain these results. However, the suppressive effects of NES on the development of allergen-specific Th2 responses was independent upon IFN-gamma or TLR-4 and still observed in mice treated with LPS-depleted NES. NES reduced OVA-induced Th2 responses also in a IL-10-independent manner. In addition, the digestion with proteinase K or the heat-treatment of NES did not abolish its ability to inhibit allergen-induced Th2 responses. Interestingly, NES suppress OVA-specific Th2 responses in vivo in the presence of a strong NES-specific Th2 environment. Taken together our results suggest that the helminth N. brasiliensis secretes substances which interfere with the development of allergic Th2 responses. In summary, distinct substances derived from microorganisms or helminths which may be used as potential adjuvants to prevent the development of allergic Th2 responses were identified. These findings contribute to the design of efficient vaccines protecting humans from developing allergic asthma.
1. Summary Candida albicans is an opportunistic human fungal pathogen that causes a variety of infections, ranging from superficial mucosal to deep-seated systemic infections, especially in immunocompromised patients. Although the ability of C.albicans to cause disease largely depends on the immune status of the host, the fungus also exhibits specific characteristics that facilitate colonization, dissemination, and adaptation to different host niches and thereby turn C.albicans from a harmless commensal to an aggressive pathogen. In response to various environmental stimuli C.albicans switches from growth as a budding yeast to invasive filamentous growth, and this morphogenetic switch plays an important role in C.albicans pathogenesis. Nitrogen limitation is one of the signals that induce filamentous growth in C.albicans, and the control of the morphogenetic transition by nitrogen availability was studied in detail in the present work. Ammonium is a preferred nitrogen source for yeasts that is taken up into the cells by specific transporters. It was found in this study that C.albicans possesses two major ammonium transporters, encoded by the CaMEP1 and CaMEP2 genes, expression of which is induced by nitrogen starvation. Whereas mep1 or mep2 single mutants grew as well as the wild-type strain on limiting concentrations of ammonium, deletion of both transporters rendered C.albicans unable to grow at ammonium concentrations below 5 mM. In contrast to mep1 mutants, mep2 mutants failed to filament and grew only in the yeast form under nitrogen starvation conditions, indicating that in addition to its role as an ammonium transporter CaMep2p also has a signaling function in the induction of filamentous growth. CaMep2p was found to be a less efficient ammonium transporter than CaMep1p and to be expressed at much higher levels, a distinguishing feature important for its signaling function. By the construction and analysis of serially truncated versions of CaMep2p, the C-terminal cytoplasmic tail of the protein was shown to be essential for signaling but dispensable for ammonium transport, demonstrating that these two functions of CaMep2p are separable. In C.albicans at least two signal transduction pathways, a MAP kinase cascade and a cAMP-dependent pathway ending in the transcriptional regulators Cph1p and Efg1p, respectively, control filamentous growth, and mutants defective in either one of these pathways are defective for filamentation under nitrogen starvation conditions. A hyperactive CaMEP2 allele rescued the filamentation defect of a cph1 or a efg1 mutant, but not of a cph1 efg1 double mutant or a mutant deleted for RAS1, which acts upstream of and activates both signaling pathways. Conversely, a dominant active RAS1 allele or addition of exogenous cAMP rescued the filamentation defect of mep2 mutants. These results suggest that CaMep2p activates both the MAP kinase and the cAMP pathway in a Ras1p dependent manner to promote filamentous growth under nitrogen starvation conditions. At sufficiently high concentrations, ammonium repressed filamentous growth even when the signaling pathways were artificially activated. Therefore, C.albicans has established a regulatory circuit in which a preferred nitrogen source, ammonium, serves as an inhibitor of morphogenesis that is taken up into the cell by the same transporter that induces filamentous growth in response to nitrogen starvation. Although a detailed understanding of virulence mechanisms of C.albicans may ultimately lead to novel approaches to combat infections caused by this pathogen, the identification and characterization of essential genes as potential targets for the development of antifungal drugs is a strategy favoured by most pharmaceutical companies. Therefore, C.albicans homologs of three genes that are essential in other fungi were selected in collaboration with an industrial partner and functionally characterized in this work. RAP1 encodes the repressor/activator protein 1, a transcription factor and telomere binding protein that is essential for viability in the budding yeast Saccharomyces cerevisiae. However, deletion of the C.albicans RAP1 homolog did not affect viability or growth of the mutants, suggesting that it is not a promising target. CBF1 (centromere binding factor 1) is necessary for proper chromosome segregation and transcriptional activation of methionine biosynthesis genes in S.cerevisiae and is essential for viability in the related yeasts Kluyveromyces lactis and Candida glabrata. Deletion of CBF1 in C.albicans did not result in an increased frequency of chromosome loss, indicating that it has no role in chromosome segregation in this organism. However, the C.albicans cbf1 mutants exhibited severe growth impairment, temperature sensitivity at 42°C, and auxotrophy for sulphur amino acids, suggesting that Cbf1p is a transcription factor that is important for normal growth of C.albicans. YIL19 is an essential gene in S.cerevisiae that is involved in 18S rRNA maturation. YIL19 was found to be an essential gene also in C.albicans. Conditional mutants in which the YIL19 gene could be excised from the genome by inducible, FLP-mediated recombination were non-viable and accumulated rRNA precursors, demonstrating that YIL19 is essential for this important cellular process and for viability of C.albicans and could serve as a target for the development of antifungal drugs.
In the last years more than one hundred microbial genomes have been sequenced, many of them from pathogenic bacteria. The availability of this huge amount of sequence data enormously increases our knowledge on the genome structure and plasticity, as well as on the microbial diversity and evolution. In parallel, these data are the basis for the scientific “revolution” in the field of industrial and environmental biotechnology and medical microbiology – diagnostics and therapy, development of new drugs and vaccines against infectious agents. Together with the genomic approach, other molecular biological methods such as PCR, DNA-chip technology, subtractive hybridization, transcriptomics and proteomics are of increasing importance for research on infectious diseases and public health. The aim of this work was to characterize the genome structure and -content of the probiotic Escherichia coli strain Nissle 1917 (O6:K5:H31) and to compare these data with publicly available data on the genomes of different pathogenic and non-pathogenic E. coli strains and other closely related species. A cosmid genomic library of strain Nissle 1917 was screened for clones containing the genetic determinants contributing to the successful survival in and colonization of the human body, as well as to mediate this strain’s probiotic effect as part of the intestinal microflora. Four genomic islands (GEI I-IVNissle 1917) were identifed and characterized. They contain many known fitness determinants (mch/mcm, foc, iuc, kps, ybt), as well as novel genes of unknown function, mobile genetic elements or newly identified putative fitness-contributing factors (Sat, Iha, ShiA-homologue, Ag43-homologues). All islands were found to be integrated next to tRNA genes (serX, pheV, argW and asnT, respectively). Their structure and chromosomal localization closely resembles those of analogous islands in the genome of uropathogenic E. coli strain CFT073 (O6:K2(?):H1), but they lack important virulence genes of uropathogenic E. coli (hly, cnf, prf/pap). Evidence for instability of GEI IINissle 1917 was given, since a deletion event in which IS2 elements play a role was detected. This event results in loss of a 30 kb DNA region, containing important fitness determinants (iuc, sat, iha), and therefore probably might influence the colonization capacity of Nissle 1917 strain. In addition, a screening of the sequence context of tRNA-encoding genes in the genome of Nissle 1917 was performed to identify genome wide potential integration sites of “foreign” DNA. As a result, similar “tRNA screening patterns” have been observed for strain Nissle 1917 and for the uropathogenic E. coli O6 strains (UPEC) 536 and CFT073. I. Summary 4 The molecular reason for the semi-rough phenotype and serum sensitivity of strain Nissle 1917 was analyzed. The O6-antigen polymerase-encoding gene wzy was identified, and it was shown that the reason for the semi-rough phenotype is a frame shift mutation in wzy, due to the presence of a premature stop codon. It was shown that the restoration of the O side-chain LPS polymerization by complementation with a functional wzy gene increased serumresistance of strain Nissle 1917. The results of this study show that despite the genome similarity of the E. coli strain Nissle 1917 with the UPEC strain CFT073, the strain Nissle 1917 exhibits a specific set of geno- and phenotypic features which contribute to its probiotic action. By comparison with the available data on the genomics of different species of Enterobacteriaceae, this study contributes to our understanding of the important processes such as horizontal gene transfer, deletions and rearrangements which contribute to genome diversity and -plasticity, and which are driving forces for the evolution of bacterial variants. At last, the fim, bcs and rfaH determinats whose expression contributes to the mutlicellular behaviour and biofilm formation of E. coli strain Nissle 1917 have been characterized.
The present investigation report a protocol to obtain dendritic cells (DC) that protects mice against fatal leishmaniasis. DC were generated from bone marrow precursors, pulsed with leishmanial antigen and activated with CpG oligodeoxinucleotides. Mice that were vaccinated with these cells were strongly protected against the clinical and parasitological manifestations of leishmaniasis and developed a Th1 immune response. protection was solid and long-lasting, and was also dependent of the via of administration. Whe the mechanism of protection was studied, it was observed that the availability of the cytokine interleukin-12 at the time of vaccination was a key requirement, but that the source of this cytokine is not the donor cells but unidentified cells from the recipients.